Prostate Cancer in a Transgender Woman 41 Years After Initiation of Feminization
Authors:
- Rebecca A. MiksadRMRebecca A. Miksad
- Glenn BubleyGBGlenn Bubley
- Paul ChurchPCPaul Church
- Martin SandaMSMartin Sanda
- Neil RofskyNRNeil Rofsky
- Irving KaplanIKIrving Kaplan
- Amiel CooperACAmiel Cooper
- 15 November 2006
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA
- Vol. 296 (19) , 2312-2317
Abstract
To the Editor: The development of prostate cancer after orchiectomy is rare. In transgender women, the longest duration between initiation of estrogen therapy aKeywords
This publication has 2 references indexed in Scilit:
- Biology of Progressive, Castration-Resistant Prostate Cancer: Directed Therapies Targeting the Androgen-Receptor Signaling AxisJournal of Clinical Oncology, 2005
- Metastatic prostatic carcinoma in a male‐to‐female transsexualBritish Journal of Urology, 1998